Scarica l'app Stockscreener
0.4481
1.79%
0.0079
Dopo l'orario di chiusura:
.43
-0.0181
-4.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.4402
Aprire:
$0.4295
Volume 24 ore:
982.04K
Relative Volume:
0.66
Capitalizzazione di mercato:
$183.87M
Reddito:
$306.91M
Utile/perdita netta:
$-59.11M
Rapporto P/E:
-2.9873
EPS:
-0.15
Flusso di cassa netto:
$6.35M
1 W Prestazione:
-3.53%
1M Prestazione:
-17.31%
6M Prestazione:
-28.52%
1 anno Prestazione:
-49.70%
Intervallo 1D:
$0.4295
$0.4516
Intervallo di 1 settimana:
$0.4246
$0.4795
Portata 52W:
$0.354
$1.11
Amarin Corp Adr Stock (AMRN) Company Profile
Nome
Amarin Corp Adr
Settore
Industria
Telefono
353 1 6699 020
Indirizzo
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Confronta AMRN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
0.4481 | 183.87M | 306.91M | -59.11M | 6.35M | -0.15 |
|
LLY
Lilly Eli Co
|
825.91 | 739.17B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
209.52 | 370.74B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
165.84 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
69.44 | 311.44B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
89.76 | 226.76B | 64.17B | 17.12B | 18.10B | 6.73 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-20 | Ripresa | JP Morgan | Underweight |
| 2023-10-25 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-06 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-05 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-05-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-04 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2021-05-12 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-05-05 | Iniziato | Northland Capital | Outperform |
| 2020-03-31 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-31 | Downgrade | Jefferies | Buy → Hold |
| 2020-03-31 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-03-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-02 | Iniziato | Cowen | Outperform |
| 2020-02-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-01-06 | Iniziato | JP Morgan | Neutral |
| 2019-12-16 | Downgrade | Stifel | Buy → Hold |
| 2019-11-20 | Iniziato | Oppenheimer | Underperform |
| 2019-11-18 | Downgrade | Citigroup | Buy → Neutral |
| 2019-11-15 | Reiterato | SVB Leerink | Outperform |
| 2019-10-31 | Iniziato | Aegis Capital | Buy |
| 2019-10-15 | Iniziato | Goldman | Neutral |
| 2019-08-14 | Iniziato | SVB Leerink | Outperform |
| 2019-07-09 | Reiterato | Jefferies | Buy |
| 2019-06-17 | Iniziato | ROTH Capital | Buy |
| 2019-03-22 | Iniziato | Stifel | Buy |
Mostra tutto
Amarin Corp Adr Borsa (AMRN) Ultime notizie
Assessing the Risk and Potential of Sempra’s (SRE) Stock - The News Heater
Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript - Insider Monkey
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - The Motley Fool
Amarin announce splan to initiate ratio change under ADR program - TipRanks
Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - The Manila Times
Amarin Corp. (AMRN) Announces 1-For-20 ADS Ratio Change to Maintain Nasdaq Listing - StreetInsider.com
Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - StockTitan
How Amarin's Latest European Reimbursement Victory Strengthens Its Cardiovascular Market Position - Stock Titan
Will Amarin's Q4 Earnings Mark a Turning Point? Key Date and Details Revealed - Stock Titan
Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView
Amarin Corp ADR [AMRN] Stock bought by Insider Berg Aaron for $0.1 million - Knox Daily
Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex
Checking in on Indivior Plc (INDV) after recent insiders movement - Knox Daily
Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex
Are Smart Investors Making the Right Decision? Amarin Corp ADR (AMRN) - SETE News
Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News
Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News
Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News
Amarin Corp ADR (AMRN) shows promising results - US Post News
Analysts review Amarin Corp ADR’s rating - Knox Daily
ALLY’s latest rating updates from top analysts. - Knox Daily
Ratio Review: Analyzing Caleres Inc (CAL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Financial Health Report: Tevogen Bio Holdings Inc (TVGN)’s Ratios Tell a Tale - The Dwinnex
Financial Metrics Exploration: Understanding Opendoor Technologies Inc (OPEN) Through Ratios - The Dwinnex
Potential Price Increase for Godaddy Inc (GDDY) After Recent Insider Activity - Knox Daily
Analyzing Ratios: Amarin Corp ADR (AMRN)’s Financial Story Unveiled - The Dwinnex
Establishment Labs Holdings Inc (ESTA) expanding its growth trajectory ahead - SETE News
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com
Italy grants VAZKEPA reimbursement for heart risk - Investing.com
Amarin Corporation plc (ADR) : Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) - Marketscreener.com
Amarin appoints new chief financial officer - Investing.com
Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewswire Inc.
Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com
Amarin granted extension to meet Nasdaq listing standards - Investing.com
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance
Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
A Must-See Look at Amarin's Best- and Worst-Case Scenarios - AOL
Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart
Earnings call: Amarin reports Q3 revenue dip amid U.S. generic competition - Investing.com
Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India
European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN
Amarin Corp Adr Azioni (AMRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):